159 related articles for article (PubMed ID: 3858896)
1. Lateral ventricular enlargement and clinical response in schizophrenia.
Smith RC; Baumgartner R; Ravichandran GK; Mauldin M; Burd A; Vroulis G; Gordon J; Calderon M
Psychiatry Res; 1985 Mar; 14(3):241-53. PubMed ID: 3858896
[TBL] [Abstract][Full Text] [Related]
2. Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.
Mauri MC; Vita A; Giobbio GM; Ferrara A; Dieci M; Bitetto A; Altamura AC
Int Clin Psychopharmacol; 1994; 9(1):3-7. PubMed ID: 8195579
[TBL] [Abstract][Full Text] [Related]
3. Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.
Wilms G; Van Ongeval C; Baert AL; Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S
Acta Psychiatr Scand; 1992 Apr; 85(4):306-12. PubMed ID: 1375802
[TBL] [Abstract][Full Text] [Related]
4. Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics.
Smith RC; Baumgartner R; Ravichandran GK; Largen J; Calderon M; Burd A; Mauldin M
Acta Psychiatr Scand; 1987 Jan; 75(1):11-9. PubMed ID: 2883814
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of body weight changes in schizophrenia.
Lawson WB; Karson CN
J Neuropsychiatry Clin Neurosci; 1994; 6(2):187-8. PubMed ID: 8044044
[TBL] [Abstract][Full Text] [Related]
6. The BPRS in assessing symptom correlates of cerebral ventricular enlargement in acute and chronic schizophrenia.
Bishop RJ; Golden CJ; MacInnes WD; Chu CC; Ruedrich SL; Wilson J
Psychiatry Res; 1983 Jul; 9(3):225-31. PubMed ID: 6604928
[TBL] [Abstract][Full Text] [Related]
7. Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures.
Losonczy MF; Song IS; Mohs RC; Small NA; Davidson M; Johns CA; Davis KL
Am J Psychiatry; 1986 Aug; 143(8):976-81. PubMed ID: 3524278
[TBL] [Abstract][Full Text] [Related]
8. Lateral ventricular size, psychopathology, and medication response in the psychoses.
Luchins DJ; Lewine RR; Meltzer HY
Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730
[TBL] [Abstract][Full Text] [Related]
9. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle:brain ratio (VBR).
Van Horn JD; McManus IC
Br J Psychiatry; 1992 May; 160():687-97. PubMed ID: 1534268
[TBL] [Abstract][Full Text] [Related]
10. Familial schizophrenia and treatment response.
Silverman JM; Mohs RC; Davidson M; Losonczy MF; Keefe RS; Breitner JC; Sorokin JE; Davis KL
Am J Psychiatry; 1987 Oct; 144(10):1271-6. PubMed ID: 3661762
[TBL] [Abstract][Full Text] [Related]
11. VBR in schizophrenia: relationship to family history of psychosis and season of birth.
DeQuardo JR; Goldman M; Tandon R
Schizophr Res; 1996 Jul; 20(3):275-85. PubMed ID: 8827854
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine challenge test, response to treatment, and lateral ventricle size in schizophrenia.
Pandurangi AK; Goldberg SC; Brink DD; Hill MH; Gulati AN; Hamer RM
Biol Psychiatry; 1989 Jan; 25(2):207-14. PubMed ID: 2649157
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.
Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF
Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605
[TBL] [Abstract][Full Text] [Related]
14. Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.
Andreasen NC; Olsen SA; Dennert JW; Smith MR
Am J Psychiatry; 1982 Mar; 139(3):297-302. PubMed ID: 7058942
[TBL] [Abstract][Full Text] [Related]
15. Thioridazine improves affective symptoms in schizophrenic patients.
Dufresne RL; Valentino D; Kass DJ
Psychopharmacol Bull; 1993; 29(2):249-55. PubMed ID: 8290673
[TBL] [Abstract][Full Text] [Related]
16. Early response to haloperidol treatment in chronic schizophrenia.
Stern RG; Kahn RS; Harvey PD; Amin F; Apter SH; Hirschowitz J
Schizophr Res; 1993 Aug; 10(2):165-71. PubMed ID: 8398949
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.
Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M
Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652
[TBL] [Abstract][Full Text] [Related]
18. Atrophic and static (neurodevelopmental) schizophrenic psychoses: premorbid functioning, symptoms and neuroleptic response.
Garver DL; Nair TR; Christensen JD; Holcomb J; Ramberg J; Kingsbury S
Neuropsychopharmacology; 1999 Jul; 21(1):82-92. PubMed ID: 10379522
[TBL] [Abstract][Full Text] [Related]
19. Stability of ventricular size after the onset of psychosis in schizophrenia.
Sponheim SR; Iacono WG; Beiser M
Psychiatry Res; 1991 May; 40(1):21-9. PubMed ID: 1946839
[TBL] [Abstract][Full Text] [Related]
20. Cerebral ventricular enlargement as a generalized feature of schizophrenia: a distribution analysis on 502 subjects.
Vita A; Dieci M; Silenzi C; Tenconi F; Giobbio GM; Invernizzi G
Schizophr Res; 2000 Jul; 44(1):25-34. PubMed ID: 10867309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
